Enhancing Topical Corticosteroid Potency in Dermatitis Treatment
Occlusive dressings should be applied after topical corticosteroid application to enhance potency when treating dermatitis. 1, 2
Mechanism of Occlusion
Occlusive dressings work by:
- Increasing skin hydration
- Enhancing medication penetration through the stratum corneum
- Preventing evaporation of the medication
- Raising local skin temperature
- Creating a moisture barrier that prolongs contact time between the medication and skin
Evidence-Based Recommendations
The FDA drug labeling for topical corticosteroids specifically mentions occlusion as a factor that augments systemic absorption 2. This increased absorption directly correlates with enhanced local potency of the medication, making it more effective for treating dermatitis.
However, caution is warranted as the FDA label for clobetasol propionate (a super-high potency corticosteroid) specifically states: "Clobetasol propionate gel, cream and ointment should not be used with occlusive dressings" 1. This warning exists because the already high potency of this medication can lead to increased risk of side effects when occluded.
Appropriate Application Technique
When using occlusion to enhance topical corticosteroid potency:
- Apply a thin layer of the prescribed corticosteroid to affected areas
- Cover with an occlusive material (plastic wrap, hydrocolloid dressing, or specialized occlusive dressing)
- Secure the edges to create a seal
- Leave in place for the prescribed duration (typically no more than a few hours)
Important Considerations and Precautions
- Duration: Limit occlusive therapy to short periods (hours rather than days) to minimize adverse effects
- Monitoring: Watch for signs of skin atrophy, striae, or secondary infection
- Anatomical location: Avoid occlusion on the face, genitals, and intertriginous areas where skin is already thin
- Patient selection: Use with caution in children who may absorb proportionally larger amounts of medication 2
- Infection risk: Do not use occlusion if there is active infection, as occlusion can promote bacterial or fungal growth
Special Populations
For pediatric patients, the FDA warns that "pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced HPA axis suppression and Cushing's syndrome than mature patients because of a larger skin surface area to body weight ratio" 2. Therefore, occlusion should be used even more cautiously in children.
Alternative Methods to Enhance Potency
If occlusion is contraindicated, other methods to enhance topical corticosteroid efficacy include:
- Using a higher potency formulation
- Selecting an ointment base rather than a cream or lotion
- Applying after bathing when skin is hydrated
- Increasing frequency of application (within prescribing guidelines)
Common Pitfalls to Avoid
- Prolonged occlusion leading to skin maceration or infection
- Occluding high-potency steroids on thin-skinned areas
- Failing to monitor for signs of increased systemic absorption
- Using occlusion with medications specifically contraindicated for occlusive therapy
Remember that while occlusion enhances potency, it also increases the risk of local and systemic adverse effects. Always follow the specific instructions provided by the prescribing clinician regarding duration and frequency of occlusive therapy.